title: Benzodiazepines may reduce the effectiveness of ketamine in the treatment of depression.
authors.affiliation: Discipline of Psychiatry, The University of Adelaide, Adelaide, SA, Australia.
authors.forename: Nick
authors.initials: N
authors.lastname: Ford
authors.affiliation: Discipline of Acute Care Medicine, The University of Adelaide, Adelaide, SA, Australia.
authors.forename: Guy
authors.initials: G
authors.lastname: Ludbrook
authors.affiliation: Discipline of Psychiatry, The University of Adelaide, Adelaide, SA, Australia cherrie.galletly@adelaide.edu.au.
authors.forename: Cherrie
authors.initials: C
authors.lastname: Galletly
mesh_terms: D000928:Antidepressive Agents / Q000627:therapeutic use*; D018692:Antimanic Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001569:Benzodiazepines / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy*; D061218:Depressive Disorder, Treatment-Resistant / Q000188:drug therapy*; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005473:Fluoxetine / Q000627:therapeutic use; D006801:Humans; D007649:Ketamine / Q000627:therapeutic use*; D018020:Lithium Compounds / Q000627:therapeutic use; D008140:Lorazepam / Q000627:therapeutic use*; D008875:Middle Aged; D000069348:Quetiapine Fumarate / Q000627:therapeutic use
chemical_list: D000928:Antidepressive Agents; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D018020:Lithium Compounds; D005473:Fluoxetine; D001569:Benzodiazepines; D000069348:Quetiapine Fumarate; D007649:Ketamine; D008140:Lorazepam